AstraZeneca Pharma India Ltd

NSE: ASTRAZEN · BSE: 506820 · Pharmaceuticals & Biotechnology · 42 announcements

Share price: ₹5,848.50
Market cap: ₹14,621 Cr
Revenue (annual): ₹2,276 Cr
Net profit (annual): ₹187.5 Cr
P/E (TTM): 86.2×Sector 47.4×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 2.68%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 8 Regulatory Approval 6 Legal & Regulatory 6 Other Announcement 5 Annual General Meeting 4 Financial Results 3 Results Update 2 Dividend 2 Board Meeting Date 2 Capacity Expansion 1 Business Update 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

11 Aug 2026 00:39 IST NSE

Results Update

AstraZeneca Pharma India Results Update

AstraZeneca reported 30% revenue growth to ₹682.8 Crore in Q1 FY2026-27, driven by strong performance across its core Oncology and Biopharmaceutical therapy areas.

Value: ₹682.8 Cr

Read the filing ↗

26 May 2026 19:43 IST NSE

Results Update

AstraZeneca Pharma India Results Update

AstraZeneca Pharma India reported FY 2025-26 revenue of ₹2,275.58 Crore, marking 33% growth. The Company secured 11 regulatory approvals, reinforcing leadership in oncology and biopharmaceuticals.

Value: ₹2,276 Cr

Read the filing ↗